tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Taylor Feehley, 5 are a BUY (100%).
Analyst Taylor Feehley, carries an average stock price target met ratio of 50% that have a potential upside of 29.94% achieved within 123 days. Previously, Taylor Feehley worked at CHARDAN CAPITAL.
Taylor Feehley’s has documented 10 price targets and ratings displayed on 2 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on SYBX, Synlogic at 30-Mar-2023.
Analyst best performing recommendations are on MCRB (SERES THERAPEUTICS).
The best stock recommendation documented was for MCRB (SERES THERAPEUTICS) at 9/18/2020. The price target of $560 was fulfilled within 11 days with a profit of $47 (9.16%) receiving and performance score of 8.33.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Sell
$5
2 years 8 months 1 days ago
(09-Feb-2024)
6/6 (100%)
$-2.65 (-34.64%)
96
Hold Since 09-Feb-2024
2 years 8 months 2 days ago
(09-Feb-2024)
0/1 (0%)
$94.35 (169.54%)
Buy Since 25-Mar-2021
$1
$-0.1 (-9.09%)
2 years 8 months 2 days ago
(09-Feb-2024)
1/2 (50%)
$-0.77 (-43.50%)
424
Buy Since 19-Mar-2018
$24
$22.9 (2081.82%)
3 years 9 days ago
(02-Oct-2023)
0/2 (0%)
$21.15 (742.11%)
Buy Since 13-Dec-2018
$5.5
$4.4 (400.00%)
$20
3 years 6 months 11 days ago
(30-Mar-2023)
0/2 (0%)
$4.83 (720.90%)
